{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:51:38Z","timestamp":1791323498267,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006227","name":"Lawrence Livermore National Laboratory","doi-asserted-by":"publisher","award":["21ERD039"],"award-info":[{"award-number":["21ERD039"]}],"id":[{"id":"10.13039\/100006227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023015","name":"Advanced Research Projects Agency for Health","doi-asserted-by":"publisher","award":["AAH24039"],"award-info":[{"award-number":["AAH24039"]}],"id":[{"id":"10.13039\/100023015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017443","name":"Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007000","name":"Laboratory Directed Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-AC52-07NA27344"],"award-info":[{"award-number":["DE-AC52-07NA27344"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ymeth.2026.08.007","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:45:30Z","timestamp":1788565530000},"page":"89-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rapid cell-free antibody fragment production and binding analysis via fluorescence correlation"],"prefix":"10.1016","volume":"256","author":[{"given":"Shakiba","family":"Nikfarjam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam N.","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Chlebek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante P.","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Hoang-Phou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella M.","family":"Carrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted A.","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ymeth.2026.08.007_b0005","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1007\/s00216-010-3821-6","article-title":"Mammalian cell transfection: the present and the future","volume":"397","author":"Kim","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/j.ymeth.2026.08.007_b0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10969-005-2826-4","article-title":"Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production","volume":"6","author":"Geisse","year":"2005","journal-title":"J. Struct. Funct. Genomics"},{"issue":"2","key":"10.1016\/j.ymeth.2026.08.007_b0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pep.2004.07.015","article-title":"Transient transfection of CHO-K1-S using serum-free medium in suspension: a rapid mammalian protein expression system","volume":"40","author":"Rosser","year":"2005","journal-title":"Protein Expr. Purif."},{"issue":"3","key":"10.1016\/j.ymeth.2026.08.007_b0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tibtech.2005.01.003","article-title":"The past, present and future of cell-free protein synthesis","volume":"23","author":"Katzen","year":"2005","journal-title":"Trends Biotechnol."},{"issue":"5","key":"10.1016\/j.ymeth.2026.08.007_b0025","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.biotechadv.2011.09.016","article-title":"Cell-free protein synthesis: applications come of age","volume":"30","author":"Carlson","year":"2012","journal-title":"Biotechnol. Adv."},{"issue":"17","key":"10.1016\/j.ymeth.2026.08.007_b0030","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/cbic.201500340","article-title":"Cell-free protein synthesis: pros and cons of prokaryotic and eukaryotic systems","volume":"16","author":"Zemella","year":"2015","journal-title":"Chembiochem"},{"issue":"138","key":"10.1016\/j.ymeth.2026.08.007_b0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bej.2018.07.013","article-title":"Cell-free protein synthesis for producing \u2018difficult-to-express\u2019 proteins","volume":"15","author":"Jin","year":"2018","journal-title":"Biochem. Eng. J."},{"issue":"23","key":"10.1016\/j.ymeth.2026.08.007_b0040","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.1073\/pnas.232580399","article-title":"A cell-free protein synthesis system for high-throughput proteomics","volume":"99","author":"Sawasaki","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.ymeth.2026.08.007_b0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40259-020-00417-y","article-title":"Cell-free protein synthesis: a promising option for future drug development","volume":"34","author":"Dondapati","year":"2020","journal-title":"BioDrugs"},{"issue":"10","key":"10.1016\/j.ymeth.2026.08.007_b0050","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1073\/pnas.47.10.1588","article-title":"The dependence of cell-free protein synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides","volume":"47","author":"Nirenberg","year":"1961","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.ymeth.2026.08.007_b0055","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.biotechadv.2009.04.004","article-title":"Applications of single-chain variable fragment antibodies in therapeutics and diagnostics","volume":"27","author":"Weisser","year":"2009","journal-title":"Biotechnol. Adv."},{"issue":"2","key":"10.1016\/j.ymeth.2026.08.007_b0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/antib2020193","article-title":"in vivo applications of single chain Fv (variable domain) (scFv) fragments","volume":"2","author":"Monnier","year":"2013","journal-title":"Antibodies"},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/1804038","article-title":"The potential of Single-Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics","volume":"2024","author":"Gezehagn Kussia","year":"2024","journal-title":"J. Immunol. Res."},{"issue":"85","key":"10.1016\/j.ymeth.2026.08.007_b0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bios.2016.04.091","article-title":"Aptamers, antibody scFv, and antibody Fab\u2019 fragments: an overview and comparison of three of the most versatile biosensor biorecognition elements","volume":"15","author":"Crivianu-Gaita","year":"2016","journal-title":"Biosens. Bioelectron."},{"issue":"22","key":"10.1016\/j.ymeth.2026.08.007_b0075","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1007\/s00216-016-9585-x","article-title":"VHH antibodies: emerging reagents for the analysis of environmental chemicals","volume":"408","author":"Bever","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"10.1016\/j.ymeth.2026.08.007_b0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/elsc.201400036","article-title":"Cell\u2010free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments","volume":"14","author":"Stech","year":"2014","journal-title":"Eng. Life Sci."},{"issue":"14","key":"10.1016\/j.ymeth.2026.08.007_b0085","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2165\/00002018-200427140-00004","article-title":"Fab antibody fragments: some applications in clinical toxicology","volume":"27","author":"Flanagan","year":"2004","journal-title":"Drug Saf."},{"issue":"4","key":"10.1016\/j.ymeth.2026.08.007_b0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/protein\/gzu002","article-title":"In vitro Fab display: a cell-free system for IgG discovery","volume":"27","author":"Stafford","year":"2014","journal-title":"Protein Eng. Des. Sel."},{"issue":"8","key":"10.1016\/j.ymeth.2026.08.007_b0095","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.procbio.2013.06.008","article-title":"Single-chain antibody fragments: Purification methodologies","volume":"48","author":"Malpiedi","year":"2013","journal-title":"Process Biochem."},{"issue":"9","key":"10.1016\/j.ymeth.2026.08.007_b0100","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.ymeth.2026.08.007_b0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/antib8020028","article-title":"David vs. Goliath: the structure, function, and clinical prospects of antibody fragments","volume":"8","author":"Bates","year":"2019","journal-title":"Antibodies"},{"issue":"2","key":"10.1016\/j.ymeth.2026.08.007_b0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0301-4622(02)00022-4","article-title":"A kinetic trap is an intrinsic feature in the folding pathway of single-chain Fv fragments","volume":"96","author":"Hoyer","year":"2002","journal-title":"Biophys. Chem."},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pep.2005.09.003","article-title":"An optimized system for expression and purification of secreted bacterial proteins","volume":"46","author":"Geisbrecht","year":"2006","journal-title":"Protein Expr. Purif."},{"issue":"3","key":"10.1016\/j.ymeth.2026.08.007_b0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/antib9030039","article-title":"Optimization of methods for the production and refolding of biologically active disulfide bond-rich antibody fragments in microbial hosts","volume":"9","author":"Ban","year":"2020","journal-title":"Antibodies"},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0125","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1038\/s41598-017-12364-w","article-title":"Cell-free synthesis of functional antibodies using a coupled in vitro transcription-translation system based on CHO cell lysates","volume":"7","author":"Stech","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ymeth.2026.08.007_b0130","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1182\/blood-2006-07-030593","article-title":"Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines","volume":"109","author":"Kanter","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ymeth.2026.08.007_b0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4161\/mabs.4.2.19202","article-title":"Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system","volume":"4","author":"Yin","year":"2012","journal-title":"MAbs"},{"issue":"2","key":"10.1016\/j.ymeth.2026.08.007_b0140","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/bit.22070","article-title":"High-level cell-free synthesis yields of proteins containing site-specific non-natural amino acids","volume":"102","author":"Goerke","year":"2009","journal-title":"Biotechnol. Bioeng."},{"issue":"2\u20133","key":"10.1016\/j.ymeth.2026.08.007_b0145","article-title":"Surface plasmon resonance: principles, methods and applications in biomedical sciences","volume":"17","author":"Englebienne","year":"2003","journal-title":"J. Spectrosc."},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1208\/s12248-014-9682-8","article-title":"Emerging technologies to increase ligand binding assay sensitivity","volume":"17","author":"Fischer","year":"2015","journal-title":"AAPS J."},{"issue":"536","key":"10.1016\/j.ymeth.2026.08.007_b0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ab.2017.08.002","article-title":"Designing binding kinetic assay on the bio-layer interferometry (BLI) biosensor to characterize antibody-antigen interactions","volume":"1","author":"Kamat","year":"2017","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ab.2007.11.007","article-title":"Applications of dual-color fluorescence cross-correlation spectroscopy in antibody binding studies","volume":"374","author":"Ruan","year":"2008","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jim.2006.11.009","article-title":"Detection of weak ligand interactions of leukocyte Ig-like receptor B1 by fluorescence correlation spectroscopy","volume":"320","author":"Kuroki","year":"2007","journal-title":"J. Immunol. Methods"},{"issue":"47","key":"10.1016\/j.ymeth.2026.08.007_b0170","doi-asserted-by":"crossref","first-page":"14155","DOI":"10.1021\/bi0607047","article-title":"Interactions of two monoclonal antibodies with BNP: high resolution epitope mapping using fluorescence correlation spectroscopy","volume":"45","author":"Tetin","year":"2006","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.ymeth.2026.08.007_b0175","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1039\/c0an00995d","article-title":"Probing the binding kinetics of proinflammatory cytokine\u2013antibody interactions using dual color fluorescence cross correlation spectroscopy","volume":"136","author":"Wu","year":"2011","journal-title":"Analyst"},{"issue":"2","key":"10.1016\/j.ymeth.2026.08.007_b0180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.dyepig.2009.04.011","article-title":"Fluorescence anisotropy analysis of protein\u2013antibody interaction","volume":"83","author":"Barbero","year":"2009","journal-title":"Dyes Pigments"},{"issue":"18","key":"10.1016\/j.ymeth.2026.08.007_b0185","doi-asserted-by":"crossref","first-page":"9638","DOI":"10.1021\/acs.analchem.4c05485","article-title":"Real-time affinity measurements of proteins synthesized in cell-free lysate using fluorescence correlation spectroscopy","volume":"97","author":"Liu","year":"2025","journal-title":"Anal. Chem."},{"issue":"11","key":"10.1016\/j.ymeth.2026.08.007_b0190","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1103\/PhysRevLett.29.705","article-title":"Thermodynamic fluctuations in a reacting system\u2014measurement by fluorescence correlation spectroscopy","volume":"29","author":"Magde","year":"1972","journal-title":"Phys. Rev. Lett."},{"issue":"3","key":"10.1016\/j.ymeth.2026.08.007_b0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00185777","article-title":"Fluorescence correlation spectroscopy with high count rate and low background: analysis of translational diffusion","volume":"22","author":"Rigler","year":"1993","journal-title":"Eur. Biophys. J."},{"issue":"16","key":"10.1016\/j.ymeth.2026.08.007_b0200","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/cphc.201900517","article-title":"Determining metal ion complexation kinetics with fluorescent ligands by using fluorescence correlation spectroscopy","volume":"20","author":"Sharma","year":"2019","journal-title":"ChemPhysChem"},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1021\/acs.analchem.3c03341","article-title":"Fluorescence CORRELATION SPECTROSCOPY AS A VERSATILE METHOD TO DEFINE APTAMER\u2013PROTEIN INTERACTIONS WITH SINGLE-MOLECULE SENSItivity","volume":"96","author":"Porciani","year":"2024","journal-title":"Anal. Chem."},{"issue":"31","key":"10.1016\/j.ymeth.2026.08.007_b0210","doi-asserted-by":"crossref","first-page":"26136","DOI":"10.1074\/jbc.M112.362764","article-title":"Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo","volume":"287","author":"Beam","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymeth.2026.08.007_b0215","first-page":"9","article-title":"A comprehensive review of fluorescence correlation spectroscopy","volume":"12","author":"Yu","year":"2021","journal-title":"Front. Phys."},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/mps2010024","article-title":"A user\u2019s guide to cell-free protein synthesis","volume":"2","author":"Gregorio","year":"2019","journal-title":"Methods Protoc."},{"issue":"8013","key":"10.1016\/j.ymeth.2026.08.007_b0225","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41586-024-07385-1","article-title":"Computationally restoring the potency of a clinical antibody against omicron","volume":"629","author":"Desautels","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymeth.2026.08.007_b0230","series-title":"Principles of Fluorescence Spectroscopy","first-page":"961 p","author":"Lakowicz","year":"2007"},{"issue":"29","key":"10.1016\/j.ymeth.2026.08.007_b0235","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1021\/la5015708","article-title":"Successful FCS experiment in nonstandard conditions","volume":"30","author":"Banachowicz","year":"2014","journal-title":"Langmuir"},{"key":"10.1016\/j.ymeth.2026.08.007_b0240","doi-asserted-by":"crossref","unstructured":"Liu C, Hoang-Phou SA, Ye C, Laurence EJ, Laurence MJ, Fong EJ, et al. Real-time affinity measurements of proteins synthesized in cell-free lysate using fluorescence correlation spectroscopy [Internet]. bioRxiv; 2024 [cited 2025 Jan 17]. p. 2024.09.28.615564. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2024.09.28.615564v1 doi:10.1101\/2024.09.28.615564.","DOI":"10.1101\/2024.09.28.615564"},{"issue":"7815","key":"10.1016\/j.ymeth.2026.08.007_b0245","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2022.11.012","article-title":"Enhanced neutralization resistance of SARS-CoV-2 omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2","volume":"31","author":"Qu","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.ymeth.2026.08.007_b0255","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41577-022-00784-3","article-title":"Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses","volume":"23","author":"Chen","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.ymeth.2026.08.007_b0260","article-title":"An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB","volume":"4","author":"He","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0265","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41467-024-45171-9","article-title":"A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity","volume":"15","author":"de Campos-Mata","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0270","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1038\/s41467-024-46203-0","article-title":"Machine learning-aided design and screening of an emergent protein function in synthetic cells","volume":"15","author":"Kohyama","year":"2024","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.ymeth.2026.08.007_b0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/ijms21176324","article-title":"Evolution of Escherichia coli expression system in producing antibody recombinant fragments","volume":"21","author":"Sandomenico","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.ymeth.2026.08.007_b0280","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1007\/s00253-019-09925-6","article-title":"Soluble expression of single-chain variable fragment (scFv) in Escherichia coli using superfolder green fluorescent protein as fusion partner","volume":"103","author":"Liu","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"2","key":"10.1016\/j.ymeth.2026.08.007_b0285","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1046-5928(02)00502-8","article-title":"Overexpression of DsbC and DsbG markedly improves soluble and functional expression of single-chain Fv antibodies in Escherichia coli","volume":"26","author":"Zhang","year":"2002","journal-title":"Protein Expr. Purif."},{"issue":"11","key":"10.1016\/j.ymeth.2026.08.007_b0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/abr.abr_351_21","article-title":"Co-expression of chaperones for improvement of soluble expression and purification of an anti-HER2 scFv in Escherichia coli","volume":"26","author":"Estabragh","year":"2022","journal-title":"Adv Biomed Res."},{"key":"10.1016\/j.ymeth.2026.08.007_b0295","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fcimb.2013.00072","article-title":"Engineering production of functional scFv antibody in E. coli by co-expressing the molecule chaperone Skp","volume":"3","author":"Wang","year":"2013","journal-title":"Front Cell Infect. Microbiol."},{"key":"10.1016\/j.ymeth.2026.08.007_b0300","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3018608","article-title":"His-FLAG tag as a fusion partner of glycosylated human interferon-gamma and its mutant: gain or loss?","volume":"2017","author":"Krachmarova","year":"2017","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0305","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/07388551.2024.2342969","article-title":"Escherichia coli and Pichia pastoris: microbial cell-factory platform for \u00adfull-length IgG production","volume":"45","author":"Krishna","year":"2025","journal-title":"Crit Rev Biotechnol."},{"key":"10.1016\/j.ymeth.2026.08.007_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1085887","article-title":"A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice","volume":"10","author":"Williams","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.ymeth.2026.08.007_b0315","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1038\/s41467-019-12024-9","article-title":"A cell-free biosynthesis platform for modular construction of protein glycosylation pathways","volume":"10","author":"Kightlinger","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:12:14Z","timestamp":1791321134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202326001854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"alternative-id":["S1046202326001854"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.08.007","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid cell-free antibody fragment production and binding analysis via fluorescence correlation","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}